Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain

B. Basu, P. Correa De Sampaio, H. Mohammed, M. Fogarasi, P. Corrie, N. A. Watkins, P. A. Smethurst, W. R. English, W. H. Ouwehand, G. Murphy

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

The membrane associated MMP, MT1-MMP, is a critical pericellular protease involved in tumour cell invasion and angiogenesis and is highly up-regulated in numerous human cancers. It therefore represents an exciting new therapeutic cancer-specific target. We have generated recombinant human scFv antibodies against the non-catalytic, hemopexin domain of MT1-MMP that modulate its interactions with collagen. One of these is an effective inhibitor of the invasive capacity of cancer cells and of angiogenesis in model systems. This demonstrates that targeting sites outside the catalytic domain presents a potential novel approach to proteinase inhibition that could have applications in cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)393-403
Number of pages11
JournalInternational Journal of Biochemistry and Cell Biology
Volume44
Issue number2
DOIs
StatePublished - Feb 2012
Externally publishedYes

Keywords

  • Angiogenesis
  • Collagenolysis
  • Hemopexin
  • MT1-MMP
  • scFv

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Fingerprint

Dive into the research topics of 'Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain'. Together they form a unique fingerprint.

Cite this